HomeConcomitant medications in patients with metastatic urothelial carcinoma receiving enfortumab vedotin: real-world data from the ARON-2EV study

Concomitant Medications in Patients with Metastatic Urothelial Carcinoma Receiving Enfortumab Vedotin: Real-World Data from the ARON-2EV Study